Description
Arformoterol tartrate, soluble in DMSO, inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins.
Applications
Arformoterol tartrate can be studied for its effect on binding to beta 2-adrenergic receptors in the airway smooth muscle, leading to relaxation and bronchodilation, which helps to improve airflow and alleviate symptoms such as wheezing, shortness of breath, and coughing.